tiprankstipranks
Trending News
More News >

Guardant Health price target raised to $70 from $65 at UBS

UBS raised the firm’s price target on Guardant Health (GH) to $70 from $65 and keeps a Buy rating on the shares. Guardant Health reported a quarterly beat, with guidance raised amid better volume and average selling price, the analyst tells investors in a research note.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1